Skip to content
Telehealth Graded
State guide

Pennsylvania Medicaid and GLP-1s

If you're in Pennsylvania and Medical Assistance was paying for your Wegovy or Zepbound, it stopped on January 1, 2026. The same drugs are still covered for diabetes, sleep apnea and a handful of other diagnoses — with prior authorization. Here's what the state's own bulletin says, and what it means if you're now shopping cash-pay.

Every source on this page was read in September 2026. Each one is dated below with the date printed on the document itself.

All state guides

What changed, and what the document says

PointStatusWhat the source says
GLP-1s for weight lossNot covered

Not covered as of January 1, 2026. Pennsylvania had covered them for weight loss since January 2023.

Effective January 1, 2026, drugs containing a GLP-1 receptor agonist will not be covered for the treatment of overweight and obesity.

Commonwealth of Pennsylvania, Department of Human Services, Office of Medical Assistance Programs — Medical Assistance BulletinNovember 24, 2025

GLP-1s for other diagnosesConditions apply

Still covered, but every one of them now needs prior authorization first.

Drugs containing a GLP-1 receptor agonist will continue to be covered for all other medically accepted indications with a prior authorization.

Commonwealth of Pennsylvania, Department of Human Services, Office of Medical Assistance Programs — Medical Assistance BulletinNovember 24, 2025

SaxendaNot covered

Dropped completely — not just for weight loss. It's the only drug the bulletin singles out this way.

Saxenda (liraglutide) will no longer be covered for any indication.

Commonwealth of Pennsylvania, Department of Human Services, Office of Medical Assistance Programs — Medical Assistance BulletinNovember 24, 2025

Non-GLP-1 weight drugsCovered

Still covered, and the preferred ones skip prior authorization. Phentermine is the example the bulletin gives.

Obesity Treatment Agents that do not contain a GLP-1 receptor agonist will continue to be covered by the MA Program.

Commonwealth of Pennsylvania, Department of Human Services, Office of Medical Assistance Programs — Medical Assistance BulletinNovember 24, 2025

Quantity limitConditions apply

One month per fill. That rules out the 90-day fills that make some cash-pay plans look cheap.

Prescriptions for GLP-1 Receptor Agonists will be limited to a one-month supply per fill.

Commonwealth of Pennsylvania, Department of Human Services, Office of Medical Assistance Programs — Medical Assistance BulletinNovember 24, 2025

Why the state could do thisContext

Weight-loss drug coverage isn't something federal law requires of a state Medicaid program. Pennsylvania cites the statute in the bulletin itself.

Coverage of drugs for weight loss is an optional benefit for Medicaid programs. See 42 U.S.C. § 1396r-8(d)(2)(A).

Commonwealth of Pennsylvania, Department of Human Services, Office of Medical Assistance Programs — Medical Assistance BulletinNovember 24, 2025

How long an approval lastsContext

Six months for sleep apnea and for other non-diabetes diagnoses; twelve for diabetes.

For a GLP-1 Receptor Agonist for a diagnosis of diabetes, requests will be approved for up to 12 months.

Commonwealth of Pennsylvania, Department of Human Services, Office of Medical Assistance Programs — Medical Assistance BulletinNovember 24, 2025

Which of these companies serve Pennsylvania?

Of the 28 companies we grade, 4 publish a list of the states they are licensed in. We checked 23 more and found no such list on any page we read; 1 we have not checked either way.

3 of those lists name Pennsylvania: Gala Health, Care Bare Rx and Vita Bella. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Sources

Each document below was fetched and read in September 2026. The date shown is the one printed on the document, which is not always the date in its web address.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.